By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mizuho Securities has initiated coverage on five molecular tools firms, adding to a number of molecular diagnostics firms the investment bank began covering last month.

After the close of the market on Monday, Mizuho announced in separate reports it was covering Illumina, Life Technologies, Waters, Thermo Fisher Scientific, and Sigma-Aldrich.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.